Molecular and cellular aspects of troponin cardiomyopathies

Annals of the New York Academy of Sciences

Volumn 1015, Issue , 2004, Pages 214-224

  Gomes, Aldrin V ^a   Potter, James D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Dilated cardiomyopathy; Familial hypertrophic cardiomyopathy; Restrictive cardiomyopathy; Troponin

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; MYOSIN HEAVY CHAIN; TROPOMYOSIN; TROPONIN C; TROPONIN I; TROPONIN T;

CALCIUM CURRENT; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CODON; CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; DELETION MUTANT; ENERGY METABOLISM; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENE MUTATION; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HEART VENTRICLE TACHYCARDIA; HUMAN; MISSENSE MUTATION; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; POTASSIUM CURRENT; PROTEIN FUNCTION; RESTRICTIVE CARDIOMYOPATHY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 3042718653     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1302.018     Document Type: Conference Paper

References (49)

1. ZOT, A.S. & J.D. POTTER. 1987. Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Annu. Rev. Biophys. Biophys. Chem. 16: 535-559.
2. GOMES, A.V., J.D. POTTER & D. SZCZESNA-CORDARY. 2002. The role of troponins in muscle contraction. IUBMB Life 54: 323-333.
3. MARON, B.J., et al. 1995. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (young) adults. Circulation 92: 785-789.
4. GOMES, A.V., et al. 2004. Role of troponin T in disease. Mol. Cell. Biochem. In press.
5. NIIMURA, H., et al. 2002. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105: 446-451.
6. Li, D., et al. 2001. Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation 104: 2188-2193.
7. THIERFELDER, L., et al. 1994. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77: 701-712.
8. ANAN, R., et al. 1998. Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. Circulation 98: 391-397.
9. FORISSIER, J.F., et al. 1996. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation 94: 3069-3073.
10. LIN, T., et al. 2000. Phenotypic variation of familial hypertrophic cardiomyopathy caused by the Phe(110)'Ile mutation in cardiac troponin T. Cardiology 93: 155-162.
11. Ho, C.Y., et al. 2000. Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy. Circulation 102: 1950-1955.
12. NAKAJIMA-TANIGUCHI, C., et al. 1997. Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 29: 839-843.
13. VARNAVA, A., et al. 1999. A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart 82: 621-624.
14. RICHARD, P., et al. 2003. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107: 2227-2232.
15. VAN DRIEST, S.L., et al. 2003. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation 108: 445-451.
16. GARCIA-CASTRO, M., et al. 2003. Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients. Clin. Chem. 49: 1279-1285.
17. VARNAVA, A.M., et al. 2001. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation 104: 1380-1384.
18. KIMURA, A., et al. 1997. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat. Genet. 16: 379-382.
19. KOKADO, H., et al. 2000. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation 102: 663-669.
20. MORNER, S., et al. 2000. Deletion in the cardiac troponin I gene in a family from northern Sweden with hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 32: 521-525.
21. MOGENSEN, J., et al. 1999. Sudden cardiac death in familial hypartrophic cardiomyopathy is associated with a novel mutation in the troponin I. Circulation 100: I-618.
22. Genomics of Cardiovascular Development. 〈http://www.cardiogenomics. org.〉 2003. NHLBI Program for Genomic Applications, Beth Israel Deaconess Medical Center. August 2003.
23. HOFFMANN, B., et al. 2001. First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum. Mutat. 17: 524.
24. 2+-dependent action potential remodeling. Circ. Res. 92: 428-436.
25. VAN DER VELDEN, J., et al. 2001. Effects of calcium, inorganic phosphate, and pH on isometric force in single skinned cardiomyocytes from donor and failing human hearts. Circulation 104: 1140-1146.
26. MARON, B.J., et al. 1987. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N. Engl. J. Med. 316: 844-852.
27. SCHAUB, M.C., et al. 1997. Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J. Mol. Med. 75: 901-920.
28. MONTGOMERY, D.E., J.C. TARDIFF & M. CHANDRA. 2001. Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice. J. Physiol. 536: 583-592.
29. JOUAVILLE, L.S., et al. 1999. Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming. Proc. Natl. Acad. Sci. USA 96: 13807-13812.
30. LUO, Y., J.D. BOND & V.M. INGRAM. 1997. Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases. Proc. Natl. Acad. Sci. USA 94: 9705-9710.
31. NEUBAUER, S., et al. 1997. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96: 2190-2196.
32. KALSI, K.K., et al. 1999. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy. Eur. J. Clin. Invest. 29: 469-477.
33. SPINDLER, M., et al. 1998. Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J. Clin. Invest. 101: 1775-1783.
34. JUNG, W.I., et al. 1998. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 97: 2536-2542.
35. KAMISAGO, M., et al. 2000. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N. Engl. J. Med. 343: 1688-1696.
36. FUJINO, N., et al. 2001. Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy. Clin. Cardiol. 24: 397-402.
37. FUJINO, N., et al. 2002. A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy. Am. J. Cardiol. 89: 29-33.
38. VENKATRAMAN, G., et al. 2003. Different functional properties of troponin T mutants that cause dilated cardiomyopathy. J. Biol. Chem. 278: 41670-41676.
39. 2+-desensitizing effect of a deletion mutation delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy. Proc. Natl. Acad. Sci. USA 99: 913-918.
40. ROBINSON, P., et al. 2002. Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J. Biol. Chem. 277: 40710-40716.
41. MOGENSEN, J., et al. 2003. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. J. Clin. Invest. 111: 209-216.
42. VAN EYK, J.E., et al. 1998. Breakdown and release of myofilament proteins during ischemia and ischemia/reperfusion in rat hearts: identification of degradation products and effects on the pCa-force relation. Circ. Res. 82: 261-271.
43. MURPHY, A.M., et al. 2000. Transgenic mouse model of stunned myocardium. Science 287: 488-491.
44. FERRIERES, G., et al. 2000. Systematic mapping of regions of human cardiac troponin I involved in binding to cardiac troponin C: N- and C-terminal low affinity contributing regions. FEBS Lett. 479: 99-105.
45. NAIMI, B., et al. 2001. A tropomyosin-2 mutation suppresses a troponin I myopathy in Drosophila. Mol. Biol. Cell. 12: 1529-1539.
46. MORNER, S., et al. 2003. Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. J. Mol. Cell. Cardiol. 35: 841-849.
47. SZCZESNA, D., et al. 2000. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. J. Biol. Chem. 275: 624-630.
48. LANG, R., et al. 2002. Functional analysis of a troponin I (Arg145Gly) mutation associated with familial hypertrophic cardiomyopathy. J Biol. Chem. 277: 11670-11678.
49. 2+-saturated form. Nature 424: 35-41.